MétaCan
Menu
Back to cohort
Record W3165674658 · doi:10.1002/pbc.29089

Retiring as a pediatric hematologist‐oncologist during the COVID‐19 pandemic

2021· article· en· W3165674658 on OpenAlexaboutno aff
Philippa G. Sprinz

Bibliographic record

VenuePediatric Blood & Cancer · 2021
Typearticle
Languageen
FieldMedicine
TopicCOVID-19 and healthcare impacts
Canadian institutionsnot available
Fundersnot available
KeywordsHematologistMedicinePandemicCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEVirologyInternal medicineOncologyOutbreak

Abstract

fetched live from OpenAlex

Congratulations! Well done! Bravo! Our compliments and best wishes! Comments from my retirement party echoed in my head as I looked up at the night sky and tried to comprehend where I was in my life, retiring in the midst of a global pandemic. Unfortunately, the cloud ceiling was low; there were no stars to be seen to add perspective to my life. I planned my retirement before "Covid-19" was in the medical lexicon. I was 65 and had experienced a wonderful career as a pediatric hematologist/oncologist, training in the United Kingdom and then working in the United States for almost 40 years. Practicing as a physician has been incredibly satisfying. It has been my identity and how I presented myself to family and friends. Having given so much of my life to clinical work, I had not spent time developing other skills anywhere near as rewarding. I acquired some hobbies: diversions from the responsibilities of helping and supporting "my" patients and colleagues, but not activities to keep my mind or body vigorous when I stopped working. My brain "ticked" on patient-related issues and did not need me to find it other stimulation. As I contemplated no longer working clinically, my first thought was for "my" patients. I knew I had excellent colleagues to hand my patients on to, but I could not escape the thought that I would be letting them down by not providing their care myself. I believed I knew their health care needs best. I had a new role, however, that prompted my 2020 retirement: a move to Canada to help with grandchildren, so our children, far from family support, could pursue their own medical careers. Reflecting on my many years in practice, how things have changed! The 5-year survival rate for childhood cancer increased from 58% to 85%.1 When I started medical school, my neighbor's nephew died of ALL, 3 months into his diagnosis. He was so cushingoid. That was a time "when care for children with cancer was only compassion."2 For individuals with sickle cell disease (SCD) (my area of expertise), the survival gain was more modest: in the 1970s (10 years before my fellowship) 80% of individuals with SCD died by age 303 and now life expectancy is currently believed to be 54 years for both sexes.4 Clearly, there is much work to be done, but I look to the future of pediatric hematology-oncology with excitement: the promise of immunotherapy, targeted therapies, gene therapies, and new drugs for sickle cell disease are either now "mainstream" or on the near horizon. It would have been nice to be there to see more of these promises realized. Then in February 2020, SARS-CoV-2 arrived. Like for everyone else, my life and plans were thrown into disarray: my retirement had to be reformatted. I could not travel to help our children: borders were closed and international travel all but halted. Plan A was to take care of our grandchildren but suddenly I was retiring with no plan A and no plan B. I was now very conflicted. I recognized that not having to share life-threatening diagnoses with families would take a weight off my shoulders. Not having to watch, helplessly, as patients suffered painful vaso-occlusive crises might allow me to sleep better at night. I would no longer struggle to concentrate at work after losing a child to an untimely death. I would cease, however, to be one of a team working painstakingly to help children and their families understand life-impacting illnesses. Despite the sadness that permeates our work, pediatric hematology-oncology has so many rewards. Stepping away from it means losing deep family relationships, daily meetings with friends and colleagues, and forgoing wonderfully stimulating interactions with the young trainees whom we are privileged to teach. I quickly learned that retirement means the loss of daily structure: no getting up so early to catch the train, no juggling bedtime with completion of that day's work and planning for the next, eating and reading just when I want to, not in stolen time between charts and lectures. I wondered then: why retire from a secure job, with rewarding work, and a sense of serving the greater good, particularly if one is fortunate enough not to experience "burn-out" and one continues in good health? I did realize that my leaving would allow a younger physician the opportunity to take a leading role in the care of patients with SCD and eventually have as rewarding a career in pediatric hematology/oncology as I had. A critical aspect of retirement from clinical work may be to afford the opportunity to replenish the workforce with younger, more adaptable workers. Individuals trained recently have newer skills and knowledge and may improve efficiency. But is that my responsibility to determine and step aside for? I also realize that junior doctors have lesser salaries than those who have been in practice for many years. Is this why my financial administrators jumped on the idea when I first discussed retirement as the solution to my helping my children in Canada? Do you have to retire and if so, how should you prepare for it? What does life look like after a fulfilling career in clinical medicine? I had never once asked myself that. It was not until the pandemic arrived that I realized I had to ask myself these hard questions. Recognizing that I could not enact plan A and move to Canada, I offered to continue in whatever capacity I could during the pandemic. Lockdown and Telehealth changed everything: very few patients were having in-person visits and my division and hospital, like other medical centers across the country, needed to rein in expenses with fewer visits and fewer health care personnel. In addition, coronavirus did not have a significant impact on children, so more pediatric help was not needed, and I am no expert in adult medicine. Six months into retirement, I am still wondering what no longer being a clinician means. Will there be a time, after the pandemic, when I can again contribute to "the greater good" and provide patient care? Is it true: "once a doctor, always a doctor?" Or maybe I will find nonclinical life satisfying: caring for my grandchildren and finding new pastimes? Having spent all of my working days caring for others, with responsibilities for making accurate diagnoses, recommending potentially curative management, and provide compassionate care, retirement means a new life: a life of giving (or doing) without the rewards of clinical practice. My advice for younger colleagues is do not wait until retirement to plan. All along the way, find activities that can be fulfilling, rewarding, and rejuvenating, so that when you do finally retire, plans A, B, and even C are ready and waiting.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.009
metaresearch head score (Gemma)0.026
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.023
Threshold uncertainty score0.076

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0090.026
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0100.003
Scholarly communication0.0050.005
Open science0.0010.006
Research integrity0.0040.015
Insufficient payload (model declined to judge)0.0230.005

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.091
GPT teacher head0.415
Teacher spread0.324 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2021
Admission routes1
Has abstractyes

Explore more

Same venuePediatric Blood & CancerSame topicCOVID-19 and healthcare impactsFrench-language works237,207